BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 9179184)

  • 1. Growth factors mediate glucocorticoid receptor function and dexamethasone-induced regression of osteoblastic lesions in hormone refractory prostate cancer.
    Koutsilieris M; Reyes-Moreno C; Sourla A; Dimitriadou V; Choki I
    Anticancer Res; 1997; 17(3A):1461-5. PubMed ID: 9179184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid receptor function possibly modulates cell-cell interactions in osteoblastic metastases on rat skeleton.
    Reyes-Moreno C; Koutsilieris M
    Clin Exp Metastasis; 1997 May; 15(3):205-17. PubMed ID: 9174122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human prostatic tumor cells in culture produce growth and differentiation factors active on osteoblasts: a new biological and clinical parameter for prostatic carcinoma.
    Festuccia C; Teti A; Bianco P; Guerra F; Vicentini C; Tennina R; Villanova I; Sciortino G; Bologna M
    Oncol Res; 1997; 9(8):419-31. PubMed ID: 9436195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells.
    Allan EH; Zeheb R; Gelehrter TD; Heaton JH; Fukumoto S; Yee JA; Martin TJ
    J Cell Physiol; 1991 Oct; 149(1):34-43. PubMed ID: 1834680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid receptor function suppresses insulin-like growth factor 1 activity in human KLE endometrial-like cells.
    Lembessis P; Kalariti N; Koutsilieris M
    In Vivo; 2004; 18(1):43-7. PubMed ID: 15011750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoblast-derived growth factors enhance adriamycin-cytostasis of MCF-7 human breast cancer cells.
    Choki I; Sourla A; Reyes-Moreno C; Koutsilieris M
    Anticancer Res; 1998; 18(6A):4213-24. PubMed ID: 9891470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone microenvironment-related growth factors, zoledronic acid and dexamethasone differentially modulate PTHrP expression in PC-3 prostate cancer cells.
    Tenta R; Sourla A; Lembessis P; Luu-The V; Koutsilieris M
    Horm Metab Res; 2005 Oct; 37(10):593-601. PubMed ID: 16278781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
    Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
    Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urokinase-type plasminogen activator: a paracrine factor regulating the bioavailability of IGFs in PA-III cell-induced osteoblastic metastases.
    Koutsilieris M; Frenette G; Lazure C; Lehoux JG; Govindan MV; Polychronakos C
    Anticancer Res; 1993; 13(2):481-6. PubMed ID: 7685989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen-dependent activation of latent transforming growth factor beta (TGF beta) by growing cultures of osteoblast-like cells.
    Yee JA; Yan L; Dominguez JC; Allan EH; Martin TJ
    J Cell Physiol; 1993 Dec; 157(3):528-34. PubMed ID: 8253864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of transforming growth factor beta on the plasminogen activator activity of normal human osteoblast-like cells and a human osteosarcoma cell line MG-63.
    Fawthrop FW; Oyajobi BO; Bunning RA; Russell RG
    J Bone Miner Res; 1992 Dec; 7(12):1363-71. PubMed ID: 1481722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional type I collagen gel system for the study of osteoblastic metastases produced by metastatic prostate cancer.
    Koutsilieris M; Sourla A; Pelletier G; Doillon CJ
    J Bone Miner Res; 1994 Nov; 9(11):1823-32. PubMed ID: 7863832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PA-III rat prostate adenocarcinoma cells (review).
    Koutsilieris M
    In Vivo; 1992; 6(2):199-203. PubMed ID: 1326342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
    Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
    Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone-related growth factors and zoledronic acid regulate the PTHrP/PTH.1 receptor bioregulation systems in MG-63 human osteosarcoma cells.
    Tenta R; Sourla A; Lembessis P; Koutsilieris M
    Anticancer Res; 2006; 26(1A):283-91. PubMed ID: 16475708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor (IGF) I down-regulates type 1 IGF receptor (IGF 1R) and reduces the IGF I response in A549 non-small-cell lung cancer and Saos-2/B-10 osteoblastic osteosarcoma cells.
    Bostedt KT; Schmid C; Ghirlanda-Keller C; Olie R; Winterhalter KH; Zapf J
    Exp Cell Res; 2001 Dec; 271(2):368-77. PubMed ID: 11716549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MG-63 osteoblast-like cells enhance the osteoprotegerin expression of PC-3 prostate cancer cells.
    Katopodis H; Philippou A; Tenta R; Doillon C; Papachroni KK; Papavassiliou AG; Koutsilieris M
    Anticancer Res; 2009 Oct; 29(10):4013-8. PubMed ID: 19846944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
    Izumi K; Mizokami A; Li YQ; Narimoto K; Sugimoto K; Kadono Y; Kitagawa Y; Konaka H; Koh E; Keller ET; Namiki M
    Prostate; 2009 Aug; 69(11):1222-34. PubMed ID: 19434660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-2 microglobulin is mitogenic to PC-3 prostatic carcinoma cells and antagonistic to transforming growth factor beta 1 action.
    Rowley DR; Dang TD; McBride L; Gerdes MJ; Lu B; Larsen M
    Cancer Res; 1995 Feb; 55(4):781-6. PubMed ID: 7850789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexamethasone enhancement of betaglycan (TGF-beta type III receptor) gene expression in osteoblast-like cells.
    Nakayama H; Ichikawa F; Andres JL; Massagué J; Noda M
    Exp Cell Res; 1994 Apr; 211(2):301-6. PubMed ID: 8143777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.